Xpect-LS Expectorant is a combination medication formulated to provide effective relief from respiratory conditions characterized by excessive mucus production and bronchospasm. It contains Ambroxol (30mg/5ml), Levosalbutamol (1mg/5ml), and Guaifenesin (50mg/5ml), each contributing distinct therapeutic actions. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Levosalbutamol, a selective β2-adrenergic receptor agonist, functions as a bronchodilator, relaxing bronchial smooth muscles to alleviate bronchospasm and enhance airflow. Guaifenesin serves as an expectorant, promoting the hydration of respiratory secretions, which aids in loosening and thinning mucus, facilitating its expectoration. The synergistic effect of these active ingredients makes Xpect-LS effective in managing symptoms associated with acute and chronic bronchitis, asthma exacerbations, and other obstructive airway diseases. It is indicated for patients experiencing productive cough with difficulty in expectoration and bronchoconstriction. Xpect-LS should be used as directed by a healthcare professional, with caution advised in patients with hypersensitivity to any component, cardiovascular disorders, or hyperthyroidism. The medication is generally well-tolerated, with adverse effects being rare and mild.